Management of E. coli Bacteremia

Criteria for Switching to Oral Antibiotics

The switch to oral antibiotics is appropriate after 2-4 days of effective intravenous therapy when the patient meets clinical stability criteria and bacteremia elimination has been documented 1
Clinical stability criteria include being afebrile for at least 48-72 hours, having negative follow-up blood cultures, absence of endocarditis, no implanted prostheses at the infection site, and no evidence of metastatic infection or suppurative complications 1

For E. coli of urinary origin, fluoroquinolones (ciprofloxacin 500-750 mg every 12 hours or levofloxacino 750 mg every 24 hours) are the first choice for oral therapy transition, with trimethoprim-sulfamethoxazole as an alternative if local resistance is <10-20% 1
Fluoroquinolones should be avoided if local E. coli resistance exceeds 10-20%, or if the patient has QT prolongation or is an elderly adult with a risk of adverse effects 2
Trimethoprim-sulfamethoxazole requires documented susceptibility and the addition of folic acid 5 mg daily to prevent antifolate effects 3

For uncomplicated bacteremia with a controlled urinary focus, 7 days of total antibiotic therapy (intravenous + oral) is not inferior to 14 days, provided clinical stability criteria are met 1
The total duration of treatment varies from 7-10 days for uncomplicated bacteremia to 4-6 weeks for complicated bacteremia or osteomyelitis 1

Follow-up blood cultures are mandatory 2-4 days after the initial culture to document bacteremia elimination before considering oral transition 1
Clinical reevaluation is necessary if fever persists beyond 7 days of treatment 1